Is the streptokinase responsible for the endothelial injury and the platelet activation during fibrinolytic therapy?
Kolev
K
K
Skopál
J
J
Nagy
Z
Z
Machovich
R
R
D003167:Complement Activation; D004730:Endothelium, Vascular / Q000187:drug effects; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D009203:Myocardial Infarction / Q000097:blood / Q000188:drug therapy; D010960:Plasminogen Activators / Q000627:therapeutic use*; D015539:Platelet Activation; D013300:Streptokinase / Q000302:isolation & purification / Q000627:therapeutic use*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D013300:Streptokinase; D010960:Plasminogen Activators; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator